Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells

Blood

Volumn 117, Issue 6, 2011, Pages 1880-1887

  Choi, Hak Jong ^a   Geng, Yanbiao ^a   Cho, Hoonsik ^a   Li, Sha ^a   Giri, Pramod Kumar ^a   Felio, Kyrie ^a   Wang, Chyung Ru ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E26 TRANSFORMATION SPECIFIC FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOSTIMULATION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL; THYMUS;

EID: 79951481125     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-309468     Document Type: Article

References (48)

1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297-336. (Pubitemid 46697911)
2. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol. 2004;4(3):231-237. (Pubitemid 38339089)
3. Matsuda JL, Naidenko OV, Gapin L, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med. 2000;192(5):741-754.
4. Behar SM, Cardell S. Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions. Semin Immunol. 2000;12(6):551-560. (Pubitemid 32055752)
5. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol. 2001;2(10):971-978. (Pubitemid 32976171)
6. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J Exp Med. 1995;182(6):2091-2096.
7. Coles MC, Raulet DH. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol. 2000;164(5):2412-2418. (Pubitemid 30115469)
8. Stanic AK, Bezbradica JS, Park JJ, et al. NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J Immunol. 2004;172(4):2265-2273. (Pubitemid 38182374)
9. Nichols KE, Hom J, Gong SY, et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med. 2005;11(3):340-345. (Pubitemid 40460564)
10. Gadue P, Morton N, Stein PL. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med. 1999;190(8):1189-1196.
11. Eberl G, Lowin-Kropf B, MacDonald HR. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J Immunol. 1999;163(8):4091-4094. (Pubitemid 29474468)
12. Chung B, Aoukaty A, Dutz J, Terhorst C, Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol. 2005;174(6):3153-3157. (Pubitemid 40354014)
13. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. A thymic precursor to the NK T cell lineage. Science. 2002;296(5567):553-555. (Pubitemid 34408679)
14. Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med. 2002;195(7):835-844. (Pubitemid 34286755)
15. Engel I, Hammond K, Sullivan BA, et al. Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection. J Exp Med. 2010;207(5):1015-1029.
16. Wang L, Carr T, Xiong Y, et al. The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol. 2010;40(9):2385-2390.
17. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol. 2010;11(3):197-206.
18. Savage AK, Constantinides MG, Han J, et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity. 2008;29(3):391-403.
19. Kovalovsky D, Uche OU, Eladad S, et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol. 2008;9(9):1055-1064.
20. Mycko MP, Ferrero I, Wilson A, et al. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development. J Immunol. 2009;182(8):4641-4648.
21. Dose M, Sleckman BP, Han J, Bredemeyer AL, Bendelac A, Gounari F. Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc Natl Acad Sci U S A. 2009;106(21):8641-8646.
22. Bezbradica JS, Hill T, Stanic AK, Van Kaer L, Joyce S. Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny. Proc Natl Acad Sci U S A. 2005;102(14):5114-5119.
23. Egawa T, Eberl G, Taniuchi I, et al. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity. 2005;22(6):705-716. (Pubitemid 40814501)
24. Hu T, Simmons A, Yuan J, Bender TP, Alberola-Ila J. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nat Immunol. 2010;11(5):435-441.
25. Matsuda JL, Gapin L, Sidobre S, et al. Homeostasis of V alpha 14i NKT cells. Nat Immunol. 2002;3(10):966-974. (Pubitemid 35154011)
26. Townsend MJ, Weinmann AS, Matsuda JL, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity. 2004;20(4):477-494. (Pubitemid 38482125)
27. Yokoyama WM. Betting on NKT and NK cells. Immunity. 2004;20(4):363-365. (Pubitemid 38482115)
28. Gallant S, Gilkeson G. ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz). 2006;54(3):149-163. (Pubitemid 44257335)
29. Hromas R, Orazi A, Neiman RS, et al. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood. 1993;82(10):2998-3004. (Pubitemid 23334925)
30. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene. 2003;303:11-34. (Pubitemid 36151767)
31. Barton K, Muthusamy N, Fischer C, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998;9(4):555-563. (Pubitemid 28499206)
32. Lacorazza HD, Miyazaki Y, Di Cristofano A, et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17(4):437-449. (Pubitemid 35223533)
33. Walunas TL, Wang B, Wang CR, Leiden JM. Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J Immunol. 2000;164(6):2857-2860. (Pubitemid 30148940)
34. Bassuk AG, Barton KP, Anandappa RT, Lu MM, Leiden JM. Expression pattern of the Ets-related transcription factor Elf-1. Mol Med. 1998;4(6):392-401. (Pubitemid 28387898)
35. Huang X, Brown C, Ni W, Maynard E, Rigby AC, Oettgen P. Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood. 2006;107(8):3153-3160.
36. Sarafova S, Siu G. A potential role for Elf-1 in CD4 promoter function. J Biol Chem. 1999;274(23):16126-16134.
37. Rellahan BL, Jensen JP, Howcroft TK, Singer DS, Bonvini E, Weissman AM. Elf-1 regulates basal expression from the T cell antigen receptor zetachain gene promoter. J Immunol. 1998;160(6):2794-2801. (Pubitemid 28136733)
38. Serdobova I, Pla M, Reichenbach P, et al. Elf-1 contributes to the function of the complex interleukin (IL)-2-responsive enhancer in the mouse IL-2 receptor alpha gene. J Exp Med. 1997;185(7):1211-1221. (Pubitemid 27172902)
39. Finco TS, Justice-Healy GE, Patel SJ, Hamilton VE. Regulation of the human LAT gene by the Elf-1 transcription factor. BMC Mol Biol. 2006;7(1):4.
40. Garrett-Sinha LA, Dahl R, Rao S, Barton KP, Simon MC. PU. 1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood. 2001;97(9):2908-2912.
41. Mandal M, Chen XR, Alegre ML, et al. Tissue distribution, regulation and intracellular localization of murine CD1 molecules. Mol Immunol. 1998;35(9):525-536. (Pubitemid 28480198)
42. Goossens PL, Jouin H, Marchal G, Milon G. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J Immunol Methods. 1990;132(1):137-144. (Pubitemid 20263871)
43. Zimmer MI, Colmone A, Felio K, Xu H, Ma A, Wang CR. A cell-type specific CD1d expression program modulates invariant NKT cell development and function. J Immunol. 2006;176(3):1421-1430. (Pubitemid 43134284)
44. Geng Y, Laslo P, Barton K, Wang CR. Transcriptional regulation of CD1D1 by Ets family transcription factors. J Immunol. 2005;175(2):1022-1029. (Pubitemid 41094987)
45. Benlagha K,Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of thymic NKT cell development. J Exp Med. 2005;202(4):485-492. (Pubitemid 41186947)
46. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development. 1999;126(14):3131-3148. (Pubitemid 29378177)
47. Randi AM, Sperone A, Dryden NH, Birdsey GM. Regulation of angiogenesis by ETS transcription factors. Biochem Soc Trans. 2009;37(Pt 6):1248-1253.
48. Oettgen P. The role of ets factors in tumor angiogenesis. J Oncol. 2010;2010:767384.